Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers

Status:
Active, not recruiting

Trial end date:
2023-05-15

Target enrollment:

Participant gender:

This project is developing a novel disease-modifying compound for Alzheimer's disease (AD).

Phase 1

Allyx Therapeutics